Literature DB >> 23090449

Chronic kidney disease: Do patients with CKD benefit from lipid-lowering therapy?

Hallvard Holdaas, Alan Jardine.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 23090449     DOI： 10.1038/nrneph.2012.240

Source DB:  PubMed          Journal:  Nat Rev Nephrol        ISSN： 1759-5061            Impact factor:   28.314


× No keyword cloud information.
  10 in total

Review 1.  Prevention of cardiovascular disease in adult recipients of kidney transplants.

Authors:  Alan G Jardine; Robert S Gaston; Bengt C Fellstrom; Hallvard Holdaas
Journal:  Lancet       Date:  2011-10-15       Impact factor: 79.321

2.  Atorvastatin and low-density lipoprotein cholesterol in type 2 diabetes mellitus patients on hemodialysis.

Authors:  Winfried März; Bernd Genser; Christiane Drechsler; Vera Krane; Tanja B Grammer; Eberhard Ritz; Tatjana Stojakovic; Hubert Scharnagl; Karl Winkler; Ingar Holme; Hallvard Holdaas; Christoph Wanner
Journal:  Clin J Am Soc Nephrol       Date:  2011-04-14       Impact factor: 8.237

3.  Long-term cardiac outcomes in renal transplant recipients receiving fluvastatin: the ALERT extension study.

Authors:  H Holdaas; B Fellström; E Cole; G Nyberg; A G Olsson; T R Pedersen; S Madsen; C Grönhagen-Riska; H-H Neumayer; B Maes; P Ambühl; A Hartmann; B Staffler; A G Jardine
Journal:  Am J Transplant       Date:  2005-12       Impact factor: 8.086

4.  Rosuvastatin in diabetic hemodialysis patients.

Authors:  Hallvard Holdaas; Ingar Holme; Roland E Schmieder; Alan G Jardine; Faiez Zannad; Gudrun E Norby; Bengt C Fellström
Journal:  J Am Soc Nephrol       Date:  2011-05-12       Impact factor: 10.121

5.  Atorvastatin in patients with type 2 diabetes mellitus undergoing hemodialysis.

Authors:  Christoph Wanner; Vera Krane; Winfried März; Manfred Olschewski; Johannes F E Mann; Günther Ruf; Eberhard Ritz
Journal:  N Engl J Med       Date:  2005-07-21       Impact factor: 91.245

Review 6.  Lipid-lowering therapy in persons with chronic kidney disease: a systematic review and meta-analysis.

Authors:  Ashish Upadhyay; Amy Earley; Jenny L Lamont; Shana Haynes; Christoph Wanner; Ethan M Balk
Journal:  Ann Intern Med       Date:  2012-08-21       Impact factor: 25.391

Review 7.  Benefits and harms of statin therapy for persons with chronic kidney disease: a systematic review and meta-analysis.

Authors:  Suetonia C Palmer; Jonathan C Craig; Sankar D Navaneethan; Marcello Tonelli; Fabio Pellegrini; Giovanni F M Strippoli
Journal:  Ann Intern Med       Date:  2012-08-21       Impact factor: 25.391

8.  Effect of fluvastatin on cardiac outcomes in renal transplant recipients: a multicentre, randomised, placebo-controlled trial.

Authors:  Hallvard Holdaas; Bengt Fellström; Alan G Jardine; Ingar Holme; Gudrun Nyberg; Per Fauchald; Carola Grönhagen-Riska; Søren Madsen; Hans-Hellmut Neumayer; Edward Cole; Bart Maes; Patrice Ambühl; Anders G Olsson; Anders Hartmann; Dag O Solbu; Terje R Pedersen
Journal:  Lancet       Date:  2003-06-14       Impact factor: 79.321

9.  Rosuvastatin and cardiovascular events in patients undergoing hemodialysis.

Authors:  Bengt C Fellström; Alan G Jardine; Roland E Schmieder; Hallvard Holdaas; Kym Bannister; Jaap Beutler; Dong-Wan Chae; Alejandro Chevaile; Stuart M Cobbe; Carola Grönhagen-Riska; José J De Lima; Robert Lins; Gert Mayer; Alan W McMahon; Hans-Henrik Parving; Giuseppe Remuzzi; Ola Samuelsson; Sandor Sonkodi; D Sci; Gultekin Süleymanlar; Dimitrios Tsakiris; Vladimir Tesar; Vasil Todorov; Andrzej Wiecek; Rudolf P Wüthrich; Mattis Gottlow; Eva Johnsson; Faiez Zannad
Journal:  N Engl J Med       Date:  2009-03-30       Impact factor: 91.245

10.  The effects of lowering LDL cholesterol with simvastatin plus ezetimibe in patients with chronic kidney disease (Study of Heart and Renal Protection): a randomised placebo-controlled trial.

Authors:  Colin Baigent; Martin J Landray; Christina Reith; Jonathan Emberson; David C Wheeler; Charles Tomson; Christoph Wanner; Vera Krane; Alan Cass; Jonathan Craig; Bruce Neal; Lixin Jiang; Lai Seong Hooi; Adeera Levin; Lawrence Agodoa; Mike Gaziano; Bertram Kasiske; Robert Walker; Ziad A Massy; Bo Feldt-Rasmussen; Udom Krairittichai; Vuddidhej Ophascharoensuk; Bengt Fellström; Hallvard Holdaas; Vladimir Tesar; Andrzej Wiecek; Diederick Grobbee; Dick de Zeeuw; Carola Grönhagen-Riska; Tanaji Dasgupta; David Lewis; William Herrington; Marion Mafham; William Majoni; Karl Wallendszus; Richard Grimm; Terje Pedersen; Jonathan Tobert; Jane Armitage; Alex Baxter; Christopher Bray; Yiping Chen; Zhengming Chen; Michael Hill; Carol Knott; Sarah Parish; David Simpson; Peter Sleight; Alan Young; Rory Collins
Journal:  Lancet       Date:  2011-06-12       Impact factor: 79.321
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.